TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
An international study analyzed genetic data from about 2.8 million people and identified 127 DNA regions associated with Alzheimer’s disease risk; 48 had not previously been mapped in this context. The findings point to microglia, specific neuron types and other brain processes, but do not establish that the associated genes cause disease or provide a clinical prediction for individuals.
An international research team has identified 127 regions of DNA associated with Alzheimer’s disease risk, including 48 not previously mapped in this context, in a study analyzing genetic data from about 2.8 million people. Published in Nature, the study offers new leads on the biological processes involved in the disease, including activity in brain immune cells and several types of neurons, but its findings do not establish that any particular genetic association causes Alzheimer’s.
Led by Ole Andreassen of the University of Oslo and Oslo University Hospital, the study brought together data from 30 research groups. The dataset included 183,620 people with Alzheimer’s. The researchers used genetic association methods to identify DNA regions linked to differences in disease risk across the study population.
The results reinforce evidence involving microglia, immune cells in the brain that help clear damaged cellular material and other substances. Co-author Shahram Bahrami said the team found genetic evidence related to microglial activation, the recruitment of immune cells and the clearance of material in the brain. The analysis also pointed to processes involving amyloid, nerve-cell repair, astrocyte activation and the insulating layer around nerve fibers.
The team also reported genetic signals enriched in specific types of neurons, adding possible avenues for research beyond immune processes. The researchers estimated that common genetic variants together account for about 16% of differences in Alzheimer’s risk between people, compared with earlier estimates of about 5%. The report attributes the higher estimate mainly to a statistical method that better accounts for APOE, a gene with a particularly large effect on risk.
New Leads Across Brain Cell Types
The study adds detail to researchers’ picture of the biology associated with Alzheimer’s, a disease for which the specific genes and processes involved remain incompletely understood. Mapping more genetic associations can help scientists prioritize biological pathways for further study and design laboratory models to investigate how those pathways behave.
These findings may help researchers identify possible targets for future medicines, but they are starting points for investigation, not evidence that acting on a particular gene or process will produce a safe, effective treatment. The population-level estimate for common variants also should not be read as a personal forecast: it does not mean that genes account for 16% of an individual’s disease or determine whether that person will develop Alzheimer’s.
Popular right now
Shark HydroVac MessMaster Corded Wet/Dry Vacuum, Mop & Self-Clean (WD161)
TCL T7 Series 85-Inch 4K 144Hz QLED Smart Google TV
Apple AirPods Pro 3 Wireless Earbuds with Active Noise Cancellation
As an affiliate, we earn on qualifying purchases.
How the Study Expanded the Search
Earlier estimates suggested that common genetic variants explained about 5% of differences in Alzheimer’s risk. According to the report, that figure contributed to the view that genetic association studies might have limited additional findings. The new estimate is higher, in part because the researchers used a method designed to account more effectively for APOE’s unusually large influence.
Combining data across 30 research groups enabled the team to analyze a much larger sample than individual studies could provide. Co-author Alexey Shadrin described it as the largest Alzheimer’s genetic association study to date and said it included people from diverse genetic backgrounds. The source report does not provide a breakdown of participant numbers or results by ancestry, so the extent of representation across groups cannot be assessed from the available details.
“This is the largest genetic association study on Alzheimer’s to date, bringing together data from individuals with diverse genetic backgrounds.”
— Alexey Shadrin, study co-author
Association Is Not Causation
The study identifies genetic associations; it does not show that every associated region causes Alzheimer’s or explain how each signal affects disease development. Follow-up work is needed to determine which associations have a causal role and whether changing the related biological processes would be safe and useful.
The findings also do not establish that the genetic risk models are ready for clinical use. The report says their current relevance is mainly for research and that any future role in health care requires further investigation. A genetic score cannot account for all influences on risk, which also include age, environment and other biological and personal factors.
Follow-Up Studies and Treatment Research
Researchers can use the mapped regions to select genes and biological processes for laboratory studies, including models designed to examine brain immune activity, neuron types and other pathways flagged by the analysis. Future research will need to test which associations are causal and whether targeting any of them could lead to meaningful treatments.
The study’s authors also identify the responsible use of genetic risk prediction as an open research question. The source report does not announce a timeline for follow-up studies or a planned clinical application. For now, the results are best understood as a broader set of research leads rather than a change to diagnosis or treatment.
Key Questions
What did the Alzheimer’s genetic study find?
Researchers identified 127 DNA regions associated with Alzheimer’s risk, including 48 not previously mapped in this context. The results also highlighted genetic signals linked to microglia, specific neuron types and other brain processes.
Does the study show that these genes cause Alzheimer’s?
No. The results show genetic associations, not proof that each associated region causes the disease. Further research is needed to establish which signals have causal effects.
Does the 16% estimate describe an individual’s risk?
No. The estimate refers to how much common genetic variants explain differences in risk across the study population. It does not mean genes cause 16% of one person’s Alzheimer’s or determine whether that person will develop the disease.
Can the findings guide Alzheimer’s treatment now?
Not directly. The researchers describe the genetic findings as starting points for further research. The study does not show that targeting any identified gene or process would be safe or effective as a treatment.
Source: news-medical.net
